LUDIOMIL

This brand name is authorized in Austria, Spain, France, Japan, Poland, Turkey, South Africa

Active ingredients

The drug LUDIOMIL contains one active pharmaceutical ingredient (API):

1 Maprotiline UNII 7C8J54PVFI - MAPROTILINE HYDROCHLORIDE

Maprotiline is a tetracyclic antidepressant, psychoanaleptics, non-selective mono-amine reuptake inhibitor, which shares a number of basic therapeutic properties with the tricyclic antidepressants. It displays a well-balanced spectrum of action, brightening mood and alleviating anxiety, agitation and psychomotor retardation. In masked depression, it can exert a favourable influence on somatic symptoms. Read about Maprotiline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUDIOMIL Film coated tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AA21	Maprotiline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 51648, 55706
Country: FR	Base de données publique des médicaments	Identifier(s): 63912862, 67798274
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179008F1022, 1179008F2029
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100039803, 100039915, 100325621
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699708091483, 8699708091490, 8699708091506, 8699708091513, 8699708091520, 8699708091537
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/1.2/210, E/1.2/211, E/1.2/212, E/1.2/213, H/1.2/1